Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 870-873

  Willems, Marc ^a   Sterneck, Martina ^a   Langer, Florian ^a   Jung, Roman ^a   Haddad, Munif ^a   Hagel, Christian ^a   Kuetemeier, Robert ^a   Eifrig, Barbara ^a   Broering, Dieter ^a   Fischer, Lutz ^a   Rogiers, Xavier ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALPHA INTERFERON; ANTICOAGULANT AGENT; BASILIXIMAB; BLOOD CLOTTING FACTOR 5 LEIDEN; CERTOPARIN; FIBRINOLYTIC AGENT; NADROPARIN; PHENPROCOUMON; PREDNISOLONE; TACROLIMUS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DEPRESSION; FEMALE; GENE MUTATION; GENETIC DISORDER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEPATITIS C; HOMOZYGOSITY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; LIVING DONOR; MOLECULAR GENETICS; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; SCREENING TEST; THROMBOEMBOLISM;

EID: 0041561261     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50136     Document Type: Article

References (13)

1. Humar A, Khwaja K, Sielaff TD, Lake JR, Payne WD. Technique of split-liver transplant for two adult recipients. Liver Transpl 2002;8:725-729.
2. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
3. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231.
4. Ishitani M, Angle J, Bickston S, Caldwell S, Isaacs R, Pruett T. Liver transplantation: Incidence and management of deep venous thrombosis and pulmonary emboli. Transplant Proc 1997;29:2861-2863.
5. Gane E, Langley P, Williams R. Massive fluid loss and coagulation disturbances after liver transplantation. Gastroenterology 1995:109:1631-1638.
6. Schuetze SM, Linenberger M. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. Transplantation 1999;67:1366-1369.
7. Cransac M, Carles J, Bernard PH, Malavialle P, Freyburger G, Winnock S, Saric J. Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transpl Int 1995;8:307-311.
8. Gillis S, Lebenthal A, Pogrebijsky G, Levy Y, Eldor A, Eid A. Severe thrombotic complications associated with activated protein C resistance acquired by orthotopic liver transplantation. Haemostasis 2000;30:316-320.
9. Hirshfield G, Collier JD, Brown K, Taylor C, Frick T, Baglin TP, Alexander GJM. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998;4:58-61.
10. Wuthrich RP. Factor V Leiden mutation: Potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis. Curr Opin Neprol Hypertens 2001;10:409-414.
11. Bauer KA. The thrombophilias: Well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001;135: 367-373.
12. Manucci PM. Genetic hypercoagulability: Prevention suggests testing family members. Blood 2001;98:21-22.
13. Camire RM, Pollak ES, Kaushansky K, Tracy PB. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998;92:3035-3041.